These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32825)

  • 1. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of minimal cardiac transit times in normal persons during beta-sympathicolysis (author's transl)].
    Freundlieb C; Höck A; Vyska K; Smolarz A; Feinendegen LE
    Nuklearmedizin; 1979; 18(6):274-7. PubMed ID: 43966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
    Weth G; Schneider J; Rodatz H; Haubitz I
    Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.
    Sziegoleit W; Block HU; Fahr A; Mest HJ
    Pharmazie; 1991 Jan; 46(1):58-9. PubMed ID: 1677468
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of propranolol and metoprolol on beta-adrenergic metabolic responses (author's transl)].
    Chowanetz W; Müller K; Gross W
    Med Klin; 1979 Sep; 74(36):1286-90. PubMed ID: 492050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
    Ishihara T; Watanabe K; Takenaka F
    Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical dose-frequency relation as characteristic of a beta receptor blocker].
    Klempt HW; Müller WD; Bender F
    Verh Dtsch Ges Inn Med; 1973; 79():1015-8. PubMed ID: 4151337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.